
Motley Rice LLC is one of the nation's largest plaintiffs' litigation firms. Motley Rice attorneys gained recognition for their pioneering work on behalf of asbestos and mesothelioma victims, the historic litigation against the tobacco industry and the representation of the 9/11 families in their groundbreaking lawsuit against terrorist financiers. Motley Rice attorneys continue to seek justice in areas including catastrophic injury; complex case resolution; securities and consumer fraud; environmental hazards and contamination; medical drugs and device defects; occupational disease and toxic torts; and transportation disasters and defects. Disclaimer: This page is offered for general information only and is not legal advice. Your accessing this page or communicating with us through it does not create an attorney-client relationship, which can only be created through a written agreement signed by you and Motley Rice LLC. Posts are not intended to solicit clients. For more information, please visit https://www.motleyrice.com/disclaimer. William H. Narwold (CT, DC, NY, SC), Donald A. Migliori (MA, MN, NY, RI, SC), Nathan D. Finch (DC, VA) and Esther Berezofsky (NJ, PA) are the attorneys responsible for this page. Motley Rice LLC, a South Carolina Limited Liability Company, is engaged in the New Jersey practice of law through Motley Rice New Jersey LLC. Esther Berezofsky attorney responsible for New Jersey practice.
We're tracking Motley Rice LLC's market expansion
How Motley Rice LLC's international expansion compares to its competitors
Bars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
Motley Rice LLCYou | 0 | 0 | — | 0 | 0 |
Paralegal
View postingMount Pleasant, SC · last mo.
Associate Attorney
View postingHartford, CT · 2mo ago
Sr Software Engineer - D365
View postingMount Pleasant, SC · last mo.
No active campaigns
Sign up to track this company and get alerted the moment something changes.
Court preliminarily approves $7.25B Roundup settlement for Non-Hodgkin's Lymphoma claims. Compensation ranges from $6,000 to $165,000+. Final approval hearing set for July 9, 2024.
Court grants preliminary approval for $7.25B Monsanto Roundup settlement, resolving claims of non-Hodgkin lymphoma caused by glyphosate-based weed killers.
Court preliminarily approves $7.25B settlement for Roundup exposure claims, covering NHL diagnoses and potential future cases over 20 years.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Motley Rice LLC's business, markets, and growth signals.

© 2026 Pubrio. All rights reserved.